ImmuCell (ICCC) Institutional Ownership → Gold Mania (From Stansberry Research) (Ad) Free ICCC Stock Alerts $5.03 +0.03 (+0.60%) (As of 05/3/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for ImmuCell (NASDAQ:ICCC)CurrentInstitutional OwnershipPercentage13.47%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$137.94KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$75.79K Get ICCC Insider Trade Alerts Want to know when executives and insiders are buying or selling ImmuCell stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ICCC Institutional Buying and Selling by Quarter Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here ImmuCell Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/26/2024 Mesirow Financial Investment Management Inc.12,178$65K0.0%N/A0.157% 11/16/2023 Essex Financial Services Inc.11,000$59K0.0%-21.4%0.142% 11/6/2023HM Payson & Co.6,000$31K0.0%-50.5%0.077% 10/24/2023 Mission Wealth Management LP10,000$53K0.0%N/A0.129% 8/14/2023Perritt Capital Management Inc.27,026$135K0.1%-8.9%0.349% 7/17/2023HM Payson & Co.12,130$62K0.0%+49.2%0.157% Get the Latest News and Ratings for ICCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter. 5/15/2023 Overbrook Management Corp32,857$168K0.0%-7.5%0.424% 4/20/2023Empire Financial Management Company LLC42,000$215K0.1%N/A0.542% 4/13/2023 Prosperity Planning Inc.16,000$82K0.0%N/A0.206% 1/13/2023 Flagship Harbor Advisors LLC14,230$87K0.0%-12.3%0.184% 10/24/2022Shufro Rose & Co. LLC62,408$467K0.0%-23.9%0.806% 8/11/2022 Overbrook Management Corp35,532$309K0.1%-22.5%0.459% 5/11/2022Bleichroeder LP71,073$686K0.1%+14.2%0.918% 5/9/2022Shufro Rose & Co. LLC82,046$792K0.1%+358.1%1.060% 2/15/2022HM Payson & Co.8,130$65K0.0%+306.5%0.105% 2/14/2022 Overbrook Management Corp75,469$604K0.1%-8.1%0.975% 2/10/2022Bleichroeder LP62,249$498K0.1%+2.7%0.804% 2/9/2022 Wealth Effects LLC15,850$127K0.1%N/A0.205% 1/18/2022Aries Wealth Management44,100$353K0.0%N/A0.570% 11/15/2021HighTower Advisors LLC18,254$169K0.0%+15.9%0.236% 11/12/2021Renaissance Technologies LLC176,322$1.65M0.0%-1.0%2.277% 11/10/2021 Essex Financial Services Inc.14,000$131K0.0%N/A0.181% 11/9/2021BlackRock Inc.14,793$138K0.0%+21.3%0.191% 10/12/2021Koshinski Asset Management Inc.2,900$27K0.0%N/A0.037% 8/17/2021Bleichroeder LP60,607$576K0.1%N/A0.783% 8/13/2021Renaissance Technologies LLC178,156$1.69M0.0%-5.0%2.303% 8/13/2021Vanguard Group Inc.147,236$1.40M0.0%+9.4%1.903% 8/12/2021Dimensional Fund Advisors LP19,408$184K0.0%+28.6%0.251% 5/14/2021Dimensional Fund Advisors LP15,096$146K0.0%N/A0.195% 5/14/2021O Shaughnessy Asset Management LLC2,842$27K0.0%N/A0.037% 5/13/2021Renaissance Technologies LLC187,578$1.81M0.0%+11.6%2.425% 5/12/2021Minerva Advisors LLC11,958$113K0.1%-17.9%0.155% 5/10/2021HighTower Advisors LLC15,754$152K0.0%-6.6%0.204% 5/7/2021BlackRock Inc.19,319$187K0.0%+10.5%0.250% 5/3/2021 Flagship Harbor Advisors LLC14,550$140K0.0%+21.3%0.201% 4/28/2021Shufro Rose & Co. LLC17,909$173K0.0%-64.7%0.248% 4/12/2021 Wedge Capital Management L L P NC20,384$197K0.0%N/A0.282% 3/10/2021HM Payson & Co.20,500$122K0.0%-30.5%0.284% 2/10/2021Renaissance Technologies LLC168,153$1.00M0.0%+7.7%2.331% 2/10/2021HighTower Advisors LLC16,874$101K0.0%+26.2%0.234% Biden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here.2/1/2021 Prosperity Planning Inc.15,000$89K0.1%N/A0.208% 12/10/2020Mercer Global Advisors Inc. ADV11,202$61K0.0%N/A0.155% 11/11/2020 Essex Financial Services Inc.20,000$109K0.0%N/A0.277% 8/14/2020RBF Capital LLC13,086$62K0.0%N/A0.181% 8/13/2020Perritt Capital Management Inc.60,000$284K0.2%-14.3%0.832% 7/31/2020Ingalls & Snyder LLC10,000$47K0.0%-89.8%0.139% 7/31/2020 Flagship Harbor Advisors LLC12,390$58K0.0%N/A0.172% 5/14/2020Wellington Management Group LLP386,260$1.46M0.0%-43.5%5.355% 5/1/2020BlackRock Inc.12,831$48K0.0%+601.1%0.178% (Data available from 1/1/2016 forward) ICCC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ICCC shares? During the previous two years, 11 institutional investors and hedge funds held shares of ImmuCell. The most heavily invested institutionals were Bleichroeder LP ($686K), Shufro Rose & Co. LLC ($467K), Empire Financial Management Company LLC ($215K), Overbrook Management Corp ($168K), Perritt Capital Management Inc. ($135K), Flagship Harbor Advisors LLC ($87K), and Prosperity Planning Inc. ($82K).Learn more on ICCC's institutional investors. What percentage of ImmuCell stock is owned by institutional investors? 13.47% of ImmuCell stock is owned by institutional investors. Learn more on ICCC's institutional investor holdings. Which institutional investors have been buying ImmuCell stock? The following institutional investors have purchased ImmuCell stock in the last 24 months: Shufro Rose & Co. LLC ($64.14K), Empire Financial Management Company LLC ($42K), Prosperity Planning Inc. ($16K), Mesirow Financial Investment Management Inc. ($12.18K), Mission Wealth Management LP ($10K), Bleichroeder LP ($8.82K), and HM Payson & Co. ($4K). How much institutional buying is happening at ImmuCell? Institutional investors have bought a total of 157,139 shares in the last 24 months. This purchase volume represents approximately $1.14M in transactions. Which ImmuCell major shareholders have been selling company stock? The following institutional investors have sold ImmuCell stock in the last 24 months: Shufro Rose & Co. LLC ($19.63K), Overbrook Management Corp ($13.02K), HM Payson & Co. ($6.13K), Essex Financial Services Inc. ($3K), Perritt Capital Management Inc. ($2.65K), and Flagship Harbor Advisors LLC ($2K). How much institutional selling is happening at ImmuCell? Institutional investors have sold a total of 46,427 shares in the last 24 months. This volume of shares sold represents approximately $324.70K in transactions. Related Companies: AWH Major Shareholders ABIO Major Shareholders OCX Major Shareholders CDIO Major Shareholders TRIB Major Shareholders BMRA Major Shareholders TKNO Major Shareholders VNRX Major Shareholders ACHV Major Shareholders NAII Major Shareholders This page (NASDAQ:ICCC) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsAutomatic Income (from home)Awesomely, LLCBiden Nomination CANCELED?The Freeport SocietyCharles Payne Demystifies OptionsUnstoppable ProsperityWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmuCell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.